DE2501787C2 - - Google Patents

Info

Publication number
DE2501787C2
DE2501787C2 DE2501787A DE2501787A DE2501787C2 DE 2501787 C2 DE2501787 C2 DE 2501787C2 DE 2501787 A DE2501787 A DE 2501787A DE 2501787 A DE2501787 A DE 2501787A DE 2501787 C2 DE2501787 C2 DE 2501787C2
Authority
DE
Germany
Prior art keywords
bismuth
preparation
solid
citrate
ammonia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2501787A
Other languages
German (de)
English (en)
Other versions
DE2501787A1 (de
Inventor
Cristopher John Johannesburg Za Mcloughlin
Ross Brock Kenmore Brisbane Au Himstedt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROCADES-PHARMA B.V., LEIDERDORP, NL
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of DE2501787A1 publication Critical patent/DE2501787A1/de
Application granted granted Critical
Publication of DE2501787C2 publication Critical patent/DE2501787C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19752501787 1974-01-18 1975-01-17 Verfahren zur herstellung von wismuthaltigen arzneipraeparaten Granted DE2501787A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE2501787A1 DE2501787A1 (de) 1975-07-24
DE2501787C2 true DE2501787C2 (pt) 1987-11-12

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752501787 Granted DE2501787A1 (de) 1974-01-18 1975-01-17 Verfahren zur herstellung von wismuthaltigen arzneipraeparaten

Country Status (18)

Country Link
JP (1) JPS5837284B2 (pt)
AT (1) AT349150B (pt)
AU (1) AU485660B2 (pt)
BE (1) BE824509A (pt)
CA (1) CA1040532A (pt)
CH (1) CH622947A5 (pt)
DE (1) DE2501787A1 (pt)
DK (1) DK151770C (pt)
ES (1) ES433908A1 (pt)
FI (1) FI750113A (pt)
FR (1) FR2258177B1 (pt)
GB (1) GB1478742A (pt)
IE (1) IE40361B1 (pt)
IT (1) IT1036072B (pt)
LU (1) LU71668A1 (pt)
NL (1) NL185130C (pt)
SE (1) SE437930B (pt)
ZA (1) ZA74385B (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901508A1 (de) * 1989-01-19 1990-07-26 Falk Pharma Gmbh Wismut enthaltendes praeparat in fester form, arzneimittel worin es enthalten ist und verfahren zu seiner herstellung
WO1992001457A1 (en) * 1990-07-20 1992-02-06 Slagel, David Products and processes for the treatment of the alimentary canal

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
EP0206626B2 (en) * 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0363502B1 (de) * 1988-10-08 1991-09-25 Dr. R. Pfleger Chemische Fabrik Gmbh Flüssiges, wismuthaltiges Arzneipräparat, Verfahren zum Herstellen desselben und seine Verwendung
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (de) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Verbesserte Wismuth-Praeparate
GB1259151A (en) * 1968-12-23 1972-01-05 Willem Jacob Serfontein Bismuth complexes

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901508A1 (de) * 1989-01-19 1990-07-26 Falk Pharma Gmbh Wismut enthaltendes praeparat in fester form, arzneimittel worin es enthalten ist und verfahren zu seiner herstellung
WO1992001457A1 (en) * 1990-07-20 1992-02-06 Slagel, David Products and processes for the treatment of the alimentary canal
GB2262286A (en) * 1990-07-20 1993-06-16 Slagel David Products and processes for the treatment of the alimentary canal
GB2262286B (en) * 1990-07-20 1994-10-12 Slagel David Products and processes for the treatment of the alimentary canal

Also Published As

Publication number Publication date
GB1478742A (en) 1977-07-06
AU7729375A (en) 1976-07-15
DK151770C (da) 1989-11-06
SE7500501L (pt) 1975-07-21
DK151770B (da) 1988-01-04
IT1036072B (it) 1979-10-30
IE40361B1 (en) 1979-05-09
FR2258177B1 (pt) 1978-07-21
NL185130C (nl) 1990-02-01
FR2258177A1 (pt) 1975-08-18
CA1040532A (en) 1978-10-17
LU71668A1 (pt) 1975-06-24
DE2501787A1 (de) 1975-07-24
AU485660B2 (en) 1977-07-28
SE437930B (sv) 1985-03-25
ZA74385B (en) 1975-08-27
CH622947A5 (en) 1981-05-15
JPS5837284B2 (ja) 1983-08-15
NL185130B (nl) 1989-09-01
NL7500552A (nl) 1975-07-22
IE40361L (en) 1975-07-18
JPS50116623A (pt) 1975-09-12
BE824509A (fr) 1975-07-17
ATA31875A (de) 1978-08-15
AT349150B (de) 1979-03-26
DK12675A (pt) 1975-09-15
ES433908A1 (es) 1976-11-16
FI750113A (pt) 1975-07-19

Similar Documents

Publication Publication Date Title
DE2501787C2 (pt)
DE68904121T2 (de) Ibuprofen-cyclodextrin-einschlusskomplexe enthaltende pharmazeutische zubereitungen.
DE69000641T2 (de) Imipramin enthaltende arzneizubereitungen.
DE2515365C2 (pt)
DE2332484A1 (de) Lutschpastillen mit verzoegerter freigabe
DE69108022T3 (de) Arzneimittel.
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE2517413A1 (de) Dermatologisch verwendbares mittel
DE1087126B (de) Verfahren zur Herstellung von wasserfreiem Ferrofumarat
DE1915798C3 (de) Antacidum-Präparat in Form einer wäßrigen Suspension
DE3000743A1 (de) Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung
DE1915497C3 (de) Arzneimittel mit hypolipidaemischer und hypocholesterinaemischer Wirksamkeit
EP0164587A2 (de) Nifedipinpräparate und Verfahren zu ihrer Herstellung
DE1936723C2 (de) Salze von Chinarindenalkoloiden und Verfahren zu ihrer Herstellung
DE1667902C3 (de) Per oral verabreichbare Zubereitungen zur Bekämpfung der Seborrhoe
CH634546A5 (de) Verfahren zur herstellung von komplexen verbindungen von aminodicarbonsaeuren mit magnesium und halogenen.
DE1043587B (de) Verfahren zur Herstellung eines Appetitzueglers
DE69100053T2 (de) Arzneimittelzusammensetzung in stabiler wässriger Suspensionsform auf der Basis von Sucralfat und einem Antacidum sowie Verfahren zu ihrer Herstellung.
DE2951132C2 (pt)
DE3901508C2 (de) Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
DE1668562C3 (de) Cergluconat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Präparate
DE2047049B2 (de) Calciumsalz der 6-(N-Acetylamino)hexansäure, Verfahren zu seiner Herstellung und Arzneimittel mit einem GeKaIt an diesem Salz
DE1282852B (de) Peroral anwendbares aescinhaltiges Arzneimittel
DE3113132A1 (de) Vincamin-cyclamat, verfahren zu seiner herstellung und dieses enthaltende arzneimittel
DE2839311C2 (de) Pharmazeutisches Präparat gegen Geschwüre

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BROCADES-PHARMA B.V., LEIDERDORP, NL

8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT. HERMANN, G., DIPL.-PHYS. DR.RER.NAT. SCHMIDT, J., DIPL.-ING. JAENICHEN, H., DIPL.-BIOL. DR.RER.NAT., PAT.-ANWAELTE TREMMEL, H., RECHTSANW., 8000 MUENCHEN